XTX Topco’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-22,605
| Closed | -$166K | – | 2936 |
|
2025
Q1 | $166K | Buy |
22,605
+11,012
| +95% | +$80.7K | 0.01% | 1750 |
|
2024
Q4 | $99K | Buy |
+11,593
| New | +$99K | 0.01% | 1760 |
|
2024
Q1 | – | Sell |
-27,942
| Closed | -$125K | – | 2171 |
|
2023
Q4 | $125K | Buy |
+27,942
| New | +$125K | 0.03% | 1083 |
|
2023
Q1 | – | Sell |
-236,851
| Closed | -$666K | – | 1552 |
|
2022
Q4 | $666K | Buy |
236,851
+184,585
| +353% | +$519K | 0.14% | 190 |
|
2022
Q3 | $217K | Buy |
52,266
+29,698
| +132% | +$123K | 0.05% | 729 |
|
2022
Q2 | $91K | Sell |
22,568
-13,199
| -37% | -$53.2K | 0.04% | 664 |
|
2022
Q1 | $177K | Buy |
35,767
+23,582
| +194% | +$117K | 0.08% | 436 |
|
2021
Q4 | $85K | Buy |
+12,185
| New | +$85K | 0.05% | 490 |
|
2021
Q3 | – | Sell |
-23,121
| Closed | -$328K | – | 951 |
|
2021
Q2 | $328K | Buy |
+23,121
| New | +$328K | 0.11% | 328 |
|